Company: ISRG
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001035267-25-000098
Chunk: 7

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 7
---
 “to improve the executive compensation program,” if properly presented at the Annual Meeting (Proposal No. 5).

6. A stockholder proposal that is titled “shareholder approval requirement for excessive golden parachutes,” if properly presented at the Annual Meeting (Proposal No. 6).

#### What are the Board’s voting recommendations?
The Board recommends that you vote your shares:

• “FOR” the election of each of the nominees to the Board (Proposal No. 1).

• “FOR” the approval, on an advisory basis, of the compensation of the Company’s NEOs (Proposal No. 2).

• “FOR” the ratification of the appointment of PwC as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2025 (Proposal No. 3).

• “FOR” the approval of the amendment and restatement of the Amended and Restated 2010 Incentive Award Plan (Proposal No. 4).

• “AGAINST” the stockholder proposal purportedly “to improve the executive compensation program,” if properly presented at the Annual Meeting (Proposal No. 5).

• “AGAINST” the stockholder proposal that is titled “shareholder approval requirement for excessive golden parachutes,” if properly presented at the Annual Meeting (Proposal No. 6).

2

### DIRECTORS AND CORPORATE GOVERNANCE

#### General Information
The Board is composed of leaders with broad and diverse experience across different arenas, including management of large global entities, technology and innovation leadership, and healthcare experience, from clinician, surgical, and executive leadership perspectives. In these positions, they have also gained industry knowledge and significant management experience, including strategic and financial planning, public company financial reporting, compliance, risk management, and leadership development. Many of the directors also have experience serving as executive officers or on boards of directors and board committees of other public companies across healthcare, technology, and more and have an in-depth understanding of corporate governance practices and trends. Other directors have significant clinical, academic, and research experience and bring unique perspectives to the Board.

The Governance and Nominating Committee of the Board and the Board believe the skills, qualities, attributes, and experiences of its current directors provide the Company with business acumen and a range of perspectives to engage each other and management to effectively address the evolving needs of the Company and represent the best interests of the Company’s stockholders. The Governance and Nominating Committee evaluates candidates recommended by stockholders using the same criteria as used for other candidates recommended